| 标题 |
Drugging the undruggable: early phase trial shows trabectedin and low-dose irinotecan downregulate EWSR1::FLI1 and has clinical activity in advanced Ewing sarcoma |
| 网址 | |
| DOI | |
| 其它 |
期刊:Trends in Cancer 作者:David S. Shulman; Katherine A. Janeway 出版日期:2026-10-01 |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人或该文件上传人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)